封面
市場調查報告書
商品編碼
1378467

阿米替林市場:按強度、按適應症、按配銷通路、按地區

Amitriptyline Market, By Strength, By Indication, By Distribution Channel, By geography

出版日期: | 出版商: Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計2023年阿米替林的全球市場規模為6.07億美元,預測期內(2023-2030年)年複合成長率為5.6%。

報告範圍 報告詳情
基準年 2022年 2023年市場規模 6.07 億美元
過去的資料 2018-2021 預測期 2023-2030
預測期年複合成長率 5.60% 2030年市場規模預測 8.888 億美元
圖 1. 2023 年阿米替林全球市場佔有率(%),依實力分類
阿米替林市場-IMG1

阿米替林是三環抗憂鬱藥物,具有鎮靜作用。阿米替林作用於某些在腦細胞之間傳遞資訊的化學信使(神經傳導物質),有助於調節情緒。它適用於成人重度憂鬱症、神經病變疼痛、慢性緊張型頭痛 (CTTH) 和偏頭痛的預防性治療。它也用於治療尿床。以錠劑形式提供。阿米替林透過增加大腦中的血清素水平來發揮作用。血清素是一種神經傳導物質,是大腦釋放到全身神經的化學物質。血清素被認為可以增強情緒、精神狀態、睡眠和身體應對疼痛的能力。

市場促進因素

憂鬱症和躁鬱症盛行率的增加預計將推動對阿米替林等三環抗憂鬱藥物的需求,並有助於全球阿米替林市場的成長

此外,主要市場參與者增加學名藥阿米替林等產品的推出預計將推動市場成長。此外,研究機構也正在進行臨床試驗,也促進了市場的成長。例如,2020年9月,加州大學評估了阿米替林對患有功能性GERD(食道(GERD))相關症狀的成年患者的生理和行為機制,宣布啟動臨床試驗。

本次測試的主要特點

  • 本報告對全球阿米替林市場進行了詳細分析,並列出了以2022年為基準年的預測期(2023-2030)的市場規模和年複合成長率。
  • 它還揭示了各個細分市場的潛在商機,並為該市場說明了一系列有吸引力的投資提案。
  • 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
  • 它根據公司亮點、產品系列、主要亮點、業績和策略等參數,介紹了全球阿米替林市場的主要企業。
  • 該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的資訊。
  • 本研究報告針對該產業的各個相關人員,如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 透過用於分析全球阿米替林市場的各種策略矩陣,將促進相關人員的決策。

目錄

第1章 調查目的和假設

  • 這項研究的目的
  • 假設
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章 市場動態、法規及趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因素
    • 市場機會
  • 影響分析
  • 主要進展
  • 最近的產品發布/核准
  • 合併、收購和合作場景
  • 法規場景
  • PEST分析
  • 波特五力分析
  • 作用機制

第4章 全球阿米替林市場 - COVID-19感染疾病的影響分析

  • 經濟影響
  • 新型冠狀病毒感染疾病(COVID-19)的流行病學
  • 對醫療保健產業的影響

第5章 阿米替林全球市場,依實力分類,2018-2030 年

  • 10毫克片劑
  • 25毫克片劑
  • 50毫克片劑
  • 75毫克片劑
  • 100毫克錠劑
  • 150毫克片劑

第6章 全球阿米替林市場,依適應症分類,2018-2030 年

  • 沮喪
  • 遺尿症
  • 偏頭痛
  • 慢性神經性疼痛
  • 其他

第7章 全球阿米替林市場,依配銷通路分類,2018-2030

  • 醫院藥房
  • 零售藥房
  • 網路藥房

第8章 全球阿米替林市場,按地區,2018-2030

  • 北美洲
  • 美國
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • ASEAN
  • 韓國
  • 其他亞太地區
  • 中東
  • GCC
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章 競爭形勢

  • Accord Healthcare Inc.
  • Viatris Inc.
  • Sandoz Inc.
  • Sun Pharmaceutical Industries Inc.
  • Vintage Pharmaceuticals Inc.
  • Zydus Pharmaceuticals USA Inc.
  • Watson laboratories Inc.
  • Torrent Pharmaceuticals Ltd.
  • Dr Reddy's Laboratories Ltd
  • Unichem Laboratories Ltd.
  • Apotex Inc.
  • Intas Pharmaceuticals Ltd

第10章 章

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI4226

Global amitriptyline market is estimated to be valued at US$ 607.0 Million in 2023 and is expected to exhibit a CAGR of 5.6% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 607.0 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 5.60% 2030 Value Projection: US$ 888.8 Mn
Figure 1. Global Amitriptyline Market Share (%), By Strength, 2023
Amitriptyline Market - IMG1

Amitriptyline is a tricyclic antidepressant with sedative effects. Amitriptyline affects certain chemical messengers (neurotransmitters) that communicate between brain cells and help regulate the mood. The drug is indicated for treating major depressive disorder, neuropathic pain, the prophylactic treatment of chronic tension type headache (CTTH), and migraine in adults. It is also used in the treatment of nocturnal enuresis. It is available in tablet form. Amitriptyline functions by boosting serotonin levels in the brain. Serotonin is a neurotransmitter, a chemical that the brain releases to the nerves throughout the body. It is supposed to boost one's mood, mental condition, sleep, and how one's body handles pain. The rise in the prevalence of anxiety and depression across the world will act as a major driver for the expansion of the global amitriptyline market.

Market Dynamics

The increasing prevalence of depression or bipolar disorder is expected to drive demand for tricyclic antidepressants such as amitriptyline, thereby contributing to the growth of the global amitriptyline market. Moreover, an increase in the product launch, such as generic amitriptyline, by the key market players is expected to drive the market growth. In addition, research institutes are also engaged in conducting clinical trials which is contributing to the growth of the market. For instance, in September 2020, the University of California announced that it had initiated a clinical trial to assess the physiological and behavioral mechanisms associated with amitriptyline in adult patients with functional GERD (Gastroesophageal reflux disease (GERD)) related symptoms.

Key features of the study:

  • This report provides an in-depth analysis of the global amitriptyline market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global amitriptyline market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Accord Healthcare Inc., Viatris Inc., Sandoz Inc., Sun Pharmaceutical Industries Inc., Vintage Pharmaceuticals Inc., Zydus Pharmaceuticals USA Inc., Watson laboratories Inc., Torrent Pharmaceuticals Ltd., Dr Reddy's Laboratories Ltd., Unichem Laboratories Ltd., Apotex Inc. and Intas Pharmaceuticals Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global amitriptyline market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global amitriptyline market

Detailed Segmentation:

  • By Strength:
    • 10 mg tablets
    • 25 mg tablets
    • 50 mg tablets
    • 75 mg tablets
    • 100 mg tablets
    • 150 mg tablets
  • By Indication:
    • Depression
    • Nocturnal Enuresis
    • Migraine
    • Chronic Neuropathic Pain
    • Others
  • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East & Africa
  • Company Profiles
    • Accord Healthcare Inc.
    • Viatris Inc.
    • Sandoz Inc.
    • Sun Pharmaceutical Industries Inc.
    • Vintage Pharmaceuticals Inc.
    • Zydus Pharmaceuticals USA Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Strength
    • Market Snapshot, By Indication
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Developments
  • Recent Product Launches/Approvals
  • Merger, Acquisition, Collaborations Scenario
  • Regulatory Scenario
  • PEST Analysis
  • Porter's Five Forces Analysis
  • Mechanism of Action

4. Global Amitriptyline Market - COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Heathcare Sector

5. Global Amitriptyline Market, By Strength, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • 10 mg tablets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • 25 mg tablets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • 50 mg tablets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • 75 mg tablets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • 100 mg tablets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • 150 mg tablets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

6. Global Amitriptyline Market, By Indication, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Depression
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Nocturnal Enuresis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Migraine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Chronic Neuropathic Pain
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

7. Global Amitriptyline Market, By Distribution Channel, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

8. Global Amitriptyline Market, By Region, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2019-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Strength, 2018 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Mn)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Strength, 2018 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Strength, 2018 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Min)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Strength, 2018 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Mn)
  • China
  • Japan
  • India
  • Australia
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Strength, 2018 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Strength, 2018 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018 - 2030, (US$ Mn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Accord Healthcare Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Viatris Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sandoz Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sun Pharmaceutical Industries Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Vintage Pharmaceuticals Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Zydus Pharmaceuticals USA Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Watson laboratories Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Torrent Pharmaceuticals Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Dr Reddy's Laboratories Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Unichem Laboratories Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Apotex Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Intas Pharmaceuticals Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

10. Section

  • Research Methodology
  • About Us